Skip to main content
. 2010 Jul 30;101(11):2333–2340. doi: 10.1111/j.1349-7006.2010.01696.x

Table 3.

 FACS profile of separated mononuclear cells

Case Pretreatment Post‐treatment
CD56+ cell CD56CD3+ T cell CD56+ cell CD56CD3+ T cell
Microarray #00 97.9 (80.9) 97.5 97.5 (n.d.) 93.7
#04 96.0 (33.7) 99.4 95.0 (31.0) 99.0
#10 86.6 (51.5) 88.4 99.1 (58.1) 98.3
#01 95.1 (95.6) 99.2 97.7 (96.6) 99.0
#16 93.1 (91.1) 95.6 93.0 (96.0) 95.4
#24 95.6 (59.7) 98.6 95.1 (63.2) 97.0
Validation #03 98.3 (86.0) 98.9 97.0 (80.2) 99.4
#05 95.3 (88.1) 99.1 95.4 (91.9) 99.5
#08 95.1 (89.6) 99.2 94.7 (81.9) 99.5
#13 97.3 (81.1) 99.3 95.8 (90.5) 99.5
#25 97.5 (81.5) 99.3 96.0 (96.3) 99.2
#12 95.4 (88.8) 99.6 96.8 (90.5) 98.7
#22 95.1 (41.1) 99.5 97.4 (34.1) 99.8
#23 98.2 (95.4) 99.6 95.3 (60.7) 98.9

The number in parenthesis represents the percentage of natural killer cells in CD56+ cells. n.d., not done.